Urology Devices Market by Type (Diagnostic Devices, Surgical Devices, Reusable Devices, Disposable Devices), by Application (Kidney Disease, Urinary Incontinence, Prostate Disorders, Urological Cancers), by End-Use Industry (Hospitals, Clinics, Ambulatory Surgical Centers), and by Region; Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Urology Devices Market was valued at USD 15.0 Billion in 2024-e and will surpass USD 23.6 Billion by 2030; growing at a CAGR of 7.9% during 2025 - 2030.

The urology devices market is a rapidly growing segment driven by the increasing prevalence of urological disorders such as kidney disease, urinary incontinence, prostate disorders, and urological cancers. With advancements in medical technologies, the market is witnessing significant improvements in diagnostic tools and surgical devices, which are enhancing patient outcomes and reducing recovery times. As the global population ages and the incidence of urological diseases rises, the demand for both diagnostic and surgical urology devices continues to grow. Urology devices play a crucial role in the effective management of these conditions, from early diagnosis to post-treatment monitoring, ensuring their prominence in healthcare settings worldwide.

Urology devices can be categorized into diagnostic devices, surgical devices, reusable devices, and disposable devices. These devices cater to various applications such as kidney disease management, urinary incontinence treatment, prostate disorder diagnosis, and cancer-related interventions. The key end-use industries for these devices include hospitals, clinics, and ambulatory surgical centers. Technological advancements in minimally invasive procedures and the increasing focus on improving quality of life for patients with chronic urological conditions are expected to further boost market growth.

Diagnostic Devices Segment is Largest Owing to Growing Demand for Early Diagnosis

Diagnostic devices form the largest segment in the urology devices market, owing to the growing emphasis on early detection and diagnosis of urological conditions. Diagnostic devices such as ultrasound machines, cystoscopes, and urodynamic testing equipment are essential for identifying a range of urological disorders, from kidney stones to prostate cancer. Early diagnosis significantly improves treatment outcomes, driving the demand for advanced diagnostic tools across healthcare facilities.

As the prevalence of urological conditions increases globally, diagnostic devices become crucial for early intervention and effective disease management. The rise in preventive healthcare and screening programs, particularly for prostate cancer and kidney disease, is propelling the growth of this segment. The continued development of non-invasive diagnostic technologies, along with increasing healthcare investments in advanced diagnostic equipment, ensures that the diagnostic devices segment will remain the largest within the urology devices market for the foreseeable future.

Surgical Devices Segment is Fastest Growing Due to Advancements in Minimally Invasive Techniques

The surgical devices segment is the fastest growing within the urology devices market, primarily due to advancements in minimally invasive techniques and robotic-assisted surgery. Surgical devices such as endoscopic instruments, laser lithotripsy devices, and robotic surgical systems are becoming increasingly popular in the treatment of urological conditions due to their precision, reduced recovery times, and minimal risk of complications.

Minimally invasive procedures like transurethral resection of the prostate (TURP) and percutaneous nephrolithotomy (PCNL) have revolutionized the treatment of urological disorders by reducing the need for traditional open surgeries. These advancements not only improve patient outcomes but also lead to quicker recovery times, resulting in a higher rate of adoption across hospitals and clinics. As the demand for less invasive procedures continues to grow, surgical devices are expected to maintain their position as the fastest growing segment in the market.

Disposable Devices Segment is Largest in Terms of Adoption Due to Hygiene and Cost-Effectiveness

Disposable devices are the largest segment in terms of adoption in the urology devices market, owing to their hygiene benefits and cost-effectiveness. Disposable urology devices, such as catheters, urine collection bags, and surgical drapes, are widely used in urological procedures and are essential for maintaining sterility and preventing infections during treatment. Hospitals and clinics increasingly prefer disposable devices for their ability to eliminate the risk of cross-contamination, particularly in high-risk procedures.

The demand for disposable urology devices is further supported by the growing preference for single-use, hygienic solutions in healthcare settings. The low cost of disposable devices, combined with their effectiveness in ensuring patient safety, contributes to their widespread adoption across the healthcare industry. As a result, the disposable devices segment is expected to continue to dominate the market, especially in regions with high healthcare standards and a strong focus on infection control.

Hospitals Are Largest End-Use Industry Due to High Patient Volume and Advanced Treatment Capabilities

Hospitals represent the largest end-use industry for urology devices, due to their ability to cater to a wide range of patients requiring urological treatments. Hospitals are equipped with the necessary infrastructure and specialized medical teams to perform advanced urological diagnostic and surgical procedures. They are the primary centers for treating conditions like kidney disease, prostate disorders, and urological cancers, making them the largest consumers of urology devices.

The availability of state-of-the-art diagnostic equipment and surgical devices in hospitals ensures that patients receive comprehensive care for complex urological conditions. As the number of urological patients continues to rise, especially in aging populations, hospitals will continue to drive the demand for advanced urology devices. Moreover, hospitals often lead in the adoption of new technologies, further solidifying their dominant role in the urology devices market.

North America Is Largest Region Due to Advanced Healthcare Systems and High Prevalence of Urological Diseases

North America is the largest region in the urology devices market, driven by its advanced healthcare infrastructure, high healthcare spending, and the increasing prevalence of urological diseases. The United States, in particular, is a major contributor to the market due to the high adoption of advanced urology devices, the presence of leading manufacturers, and strong healthcare policies that support the purchase of cutting-edge medical equipment.

In North America, there is a growing demand for minimally invasive surgical devices and diagnostic tools as healthcare providers strive to offer better patient outcomes and reduce recovery times. The prevalence of conditions such as prostate cancer, kidney disease, and urinary incontinence, which are more common in aging populations, further fuels the growth of the urology devices market in this region. With continued technological advancements and increasing healthcare awareness, North America is expected to maintain its dominance in the urology devices market.

Leading Companies and Competitive Landscape

The urology devices market is highly competitive, with key players such as Boston Scientific, Medtronic, Johnson & Johnson, Cook Medical, and Olympus Corporation leading the way. These companies offer a wide range of urology devices, including diagnostic tools, surgical instruments, and disposables, catering to both hospital and outpatient care settings.

The competitive landscape is characterized by ongoing innovation in device technology, particularly in the areas of robotic surgery, minimally invasive procedures, and diagnostic imaging. Leading companies are focusing on product development, strategic partnerships, and acquisitions to expand their product portfolios and maintain market leadership. As urology treatment technologies continue to evolve, the competition in the market is expected to intensify, driving advancements in patient care and treatment outcomes.

Recent Developments:

• Boston Scientific Corporation launched a new line of urology devices designed for enhanced prostate treatment, improving procedure outcomes and patient comfort.
• Medtronic received FDA approval for a new robotic-assisted urology surgery system that enables more accurate and minimally invasive prostate surgery.
• Johnson & Johnson announced the acquisition of a leading urology diagnostics firm to enhance its product portfolio and capabilities in non-invasive kidney disease detection.
• Stryker Corporation introduced a new portable urology diagnostic tool that simplifies the screening process for urinary tract infections and other urological disorders.
• Teleflex Incorporated expanded its urology product line by adding advanced catheters with improved materials to reduce discomfort and enhance durability.

List of Leading Companies:

• Boston Scientific Corporation
• Medtronic plc
• Johnson & Johnson Services, Inc.
• Stryker Corporation
• Fresenius Medical Care AG & Co. KGaA
• B. Braun Melsungen AG
• Cook Medical
• Teleflex Incorporated
• UroCare Inc.
• Siemens Healthineers
• C.R. Bard, Inc.
• Coloplast A/S
• Olympus Corporation
• Hoya Corporation
• Karl Storz GmbH & Co. KG

Report Scope: